Business Immo, the real estate website

Kadans Science Partner

Office 15/04/2022

"Kadans strongly believes the Life Sciences sector is only starting its journey in Europe"

BiTV Interviews welcomes Michel Leemhuis, CEO and Co-owner at Kadans Science Partner. With him, we discuss the new 70,000 sqm building in London developped by his (...)

Office 26/07/2021

AXA IM Alts raises €1.9bn for European Life Sciences investments

Paris-based global manager AXA IM Alts has raised €1.9bn of equity to accelerate investments into the Life Sciences sector. The capital raised will primarily (...)

Health / Senior 26/05/2021

Axa IM Alts’ Kadans expands Oxford footprint with Sherard building acquisition from MRP

Bought buy Axa IM Alts last autumn, Kadans Science Partner, has added The Sherard Building on Oxford Science Park, UK to its Pan-European portfolio. (...)

Finance 25/02/2021

AXA IM reports 6% growth in underlying earnings in 2020

AXA Investment Managers announces a 6% increase in underlying earnings to €279m in 2020, driven by higher revenues. Revenues increased by 4% to €1,294m, (...)

Office 10/02/2021

Life sciences, the burgeoning asset class ready to emerge in Europe

Following its October $14.6bn recapitalisation of BioMed Realty, the largest private owner of life science office buildings in the United States, Blackstone announced in (...)

Health / Senior 26/11/2020

AXA IM-Real Assets to enter European life science sector with 500 M€ acquisition of Kadans Science Partner

AXA Investment Managers - Real Assets has agreed to acquire, on behalf of clients, Kadans Science Partner, a fully integrated developer, owner and operator (...)